Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

被引：7
|
作者：
Dias, Amanda de Fraga [1 ]
Dallemole, Danieli Rosane [2 ]
Bruinsmann, Franciele Aline [2 ]
Lopes Silva, Luiz Fernando [1 ]
Cruz-Lopez, Olga [3 ,4 ]
Conejo-Garcia, Ana [3 ,4 ]
Oliveira Battastini, Ana Maria [1 ]
Maria Campos, Joaquin [3 ,4 ]
Guterres, Silvia Staniscuaski [2 ]
Pohlmann, Adriana Raffin [2 ]
Figueiro, Fabricio [1 ,5 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
[3] Fac Farm, Dept Quim Farmaceut & Organ, C Campus Cartuja S-N, Granada, Spain
[4] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain
[5] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 23期
关键词：
bozepinib; drug delivery; glioblastoma; intranasal; lipid-core nanocapsules; temozolomide; LIPID-CORE NANOCAPSULES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRANASAL DELIVERY; EXPERIMENTAL-DESIGN; GROWTH-INHIBITION; IN-VITRO; CHITOSAN; COMBINATION; GLIOMA;
D O I：
10.2217/nnm-2021-0164
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.
引用
收藏
页码：2095 / 2115
页数：21
相关论文
共 50 条
  • [21] Niosomes for nose-to-brain delivery of bromocriptine: Formulation development, efficacy evaluation and toxicity profiling
    Sita, V. G.
    Jadhav, Dhananjay
    Vavia, Pradeep
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 58
  • [22] Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma
    Ullah, Irfan
    Chung, Kunho
    Bae, Sumin
    Li, Yan
    Kim, Chunggu
    Choi, Boyoung
    Nam, Hye Yeong
    Kim, Sun Hwa
    Yun, Chae-Ok
    Lee, Kuen Yong
    Kumar, Priti
    Lee, Sang-Kyung
    MOLECULAR PHARMACEUTICS, 2020, 17 (04) : 1193 - 1204
  • [23] Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma
    Edilson Ribeiro de Oliveira Junior
    Thais Leite Nascimento
    Mariana Arraes Salomão
    Artur Christian Garcia da Silva
    Marize Campos Valadares
    Eliana Martins Lima
    Pharmaceutical Research, 2019, 36
  • [24] Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development
    Bonaccorso, Angela
    Gigliobianco, Maria Rosa
    Lombardo, Rosamaria
    Pellitteri, Rosalia
    Di Martino, Piera
    Mancuso, Antonia
    Musumeci, Teresa
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2023, 28 (02) : 248 - 263
  • [25] NOSE-TO-BRAIN DRUG DELIVERY OF NANOFORMULATIONS: PREPARATION AND IN VITRO EVALUATION
    Celikkol, Isik
    Esim, Ozge
    Hascicek, Canan
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27
  • [26] RETRACTION: Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery.
    Tzeyung, Angeline Shak.
    Md, Shadab
    Bhattamisra, Subrat Kumar
    Madheswaran, Thiagarajan
    Alhakamy, Nabil A.
    Aldawsari, Hibah M.
    Radhakrishnan, Ammu K.
    PHARMACEUTICS, 2024, 16 (06)
  • [27] Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
    Chu, Liuxiang
    Wang, Aiping
    Ni, Ling
    Yan, Xiuju
    Song, Yina
    Zhao, Mingyu
    Sun, Kaoxiang
    Mu, Hongjie
    Liu, Sha
    Wu, Zimei
    Zhang, Chunyan
    DRUG DELIVERY, 2018, 25 (01) : 1634 - 1641
  • [28] Neuroprotective and Antioxidant Effect of Naringenin-Loaded Nanoparticles for Nose-to-Brain Delivery
    Md, Shadab
    Alhakamy, Nabil A.
    Aldawsari, Hibah M.
    Asfour, Hani Zakaria
    BRAIN SCIENCES, 2019, 9 (10)
  • [29] Nanoemulsions for "Nose-to-Brain" Drug Delivery
    Bonferoni, Maria Cristina
    Rossi, Silvia
    Sandri, Giuseppina
    Ferrari, Franca
    Gavini, Elisabetta
    Rassu, Giovanna
    Giunchedi, Paolo
    PHARMACEUTICS, 2019, 11 (02):
  • [30] Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy
    Qu, Ying
    Li, Ang
    Ma, Long
    Iqbal, Sajid
    Sun, Xiao
    Ma, Wenqing
    Li, Chunyan
    Zheng, Dandan
    Xu, Zixuan
    Zhao, Zhongxi
    Ma, Dedong
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 597
12345